Zenas BioPharma Raises $118M in Series B Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Stay updated with breaking news from Patrick Enright. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Investegate announcements from Zenas BioPharma, Zenas BioPharma Secures $118 Million to Advance Its Broad Pipeline of Autoimmune Disease Therapeutics
Proceeds to fund global Phase 3 registration program for the company's lead product candidate, Obexelimab, and support the clinical development of other pipeline programsSeries B equity financing led by
After community pushback, Council member Nathan Volke revised the bill but still failed to get the necessary votes to pass a restriction on flags at Monday night’s County Council meeting.
Supply chain hitches are particularly acute for manufacturers. NJBIZ spoke with some experts about how to ease the pain.